Effects of Vitamin B1 in Type 1 Diabetic Patients

Phase 1/2 Completed 67 enrolled University Hospital, Aker The Research Council of Norway · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether benfotiamine supplementation can reduce markers of microvascular complications in type 1 diabetic patients.

Timeline

Start: 2005-08
Primary completion: 2010-06
Completion: 2011-02

Publications

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care. 2012 May;35(5):1095-7. doi: 10.2337/dc11-1895. Epub 2012 Mar 23.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Benfotiamine	Small molecule	300 mg	Oral

Effects of Vitamin B1 in Type 1 Diabetic Patients

Summary

Timeline

Publications

Drugs

Indications